Leland Loose, PhD

Prior to MMS, he has worked at Pfizer, most recently as Executive Director and Site Clinical Strategic Partnerships Head. In this role, he was responsible for management of teams involved in clinical development of alliance products, including COX2s, Macugen, Indiplon, Spiriva, and Xiaflex.

At MMS Holdings, Dr. Loose provides consulting and advisory support in the areas of drug development and regulatory affairs. He also supports internal MMS staff with protocol development, study report creation, strategies leading to preparation of materials for regulatory agency meetings, advisory committee preparation and presentation, and input on NDA and sNDA submissions. Additionally, Dr. Loose provides support to teams involved in clinical development of alliance products.

Dr. Leland Loose earned his doctorate in physiology and immunology from the University of Missouri and was a post-doctoral fellow at the Tulane University School of Medicine.